This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zenjiro Sampei: Innovator in Antibody Research
Introduction
Zenjiro Sampei is a notable inventor based in Gotemba City, Shizuoka Prefecture, Japan. He has made significant contributions to the field of antibody research, particularly in relation to viral diseases. His work has implications for public health and disease prevention.
Latest Patents
Zenjiro Sampei holds a patent for "Anti-Dengue Virus Antibodies Having Cross-Reactivity to Zika Virus and Methods of Use." This innovative patent addresses critical challenges in combating viral infections, showcasing his expertise in immunology.
Career Highlights
Sampei is associated with Chugai Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in therapeutic antibodies. His career reflects a commitment to scientific excellence and innovation.
Collaborations
He has collaborated with esteemed colleagues, including Katja Fink and Cheng-I Wang, to further enhance the impact of his research. These partnerships have fostered a collaborative environment that promotes groundbreaking discoveries.
Conclusion
Zenjiro Sampei's contributions to antibody research exemplify the importance of innovation in addressing global health challenges. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile